Tiger Jade Capital
Hong Kong, Hong Kongtigerjadecapital.com
Overview
Tiger Jade Capital is a healthcare-focused private equity firm founded in 2019, backed by Chinese CRO company Tigermed . The firm focuses on venture opportunities and mainly invests in the healthcare industry in China, covering new drugs, CRO, medical equipment, etc . Tiger Jade Capital aspires to aggregate conscious capital to improve people's well being and contribute to the community with total dedication and integrity; and as a result, deliver optimal returns for its investors .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Spot Biosystems | Jun 2026 | VC Round | Co-investor |
| Great Bay Bio | Sep 2022 | Series B | Lead |
| Guangzhou Yinming Biomedical Technology | Sep 2021 | Series A Extension | Co-investor |
| Abogen Biosciences | Aug 2021 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
